Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hung-Chih Yang

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 26, 2022
Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinomaSung-Yin Wang, Tung-Hung Su, Bang-Bin Chen, et al.
Journal of Gastroenterology and Hepatology|January 30, 2019
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infectionChen-Hua Liu, Tung-Hung Su, Chun-Jen Liu, et al.
Immunity|March 13, 2012
Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivationLiang Shan, Kai Deng, Neeta S Shroff, et al.
Journal of Virology|December 8, 2006
Novel pathway for induction of latent virus from resting CD4(+) T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latencyAnding Shen, Hung-Chih Yang, Yan Zhou, et al.
Plos One|February 26, 2013
Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infectionTung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, et al.
Hepatology International|April 22, 2021
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patientsHuei-Ru Cheng, Hung-Chih Yang, Su-Ru Lin, et al.
The Journal of Infectious Diseases|October 2, 2019
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related CirrhosisTung-Hung Su, Cheng-Yuan Peng, Tai-Chung Tseng, et al.
Journal of Gastroenterology and Hepatology|August 2, 2017
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in TaiwanChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of ParkinsonismTung-Hung Su, Hung-Chih Yang, Tai-Chung Tseng, et al.
The Journal of Experimental Medicine|June 9, 2005
Cellular immune selection with hepatitis C virus persistence in humansAndrea L Cox, Timothy Mosbruger, Qing Mao, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 26, 2022
Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinomaSung-Yin Wang, Tung-Hung Su, Bang-Bin Chen, et al.
Journal of Gastroenterology and Hepatology|January 30, 2019
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infectionChen-Hua Liu, Tung-Hung Su, Chun-Jen Liu, et al.
Immunity|March 13, 2012
Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivationLiang Shan, Kai Deng, Neeta S Shroff, et al.
Journal of Virology|December 8, 2006
Novel pathway for induction of latent virus from resting CD4(+) T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latencyAnding Shen, Hung-Chih Yang, Yan Zhou, et al.
Plos One|February 26, 2013
Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infectionTung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, et al.
Hepatology International|April 22, 2021
Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patientsHuei-Ru Cheng, Hung-Chih Yang, Su-Ru Lin, et al.
The Journal of Infectious Diseases|October 2, 2019
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related CirrhosisTung-Hung Su, Cheng-Yuan Peng, Tai-Chung Tseng, et al.
Journal of Gastroenterology and Hepatology|August 2, 2017
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in TaiwanChen-Hua Liu, Chun-Jen Liu, Tung-Hung Su, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 11, 2019
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of ParkinsonismTung-Hung Su, Hung-Chih Yang, Tai-Chung Tseng, et al.
The Journal of Experimental Medicine|June 9, 2005
Cellular immune selection with hepatitis C virus persistence in humansAndrea L Cox, Timothy Mosbruger, Qing Mao, et al.
Pageof 15